Hey Ed, just an observation. You said that you were through on this MB, but all we see is a continuation of the same and your need to get in some irrelevant last word. It's a free country and you have every right to say one thing and do another. I'm just mentioning.
This filing couldn't go in fast enough for GTHP, provided that
there's no question it's the best response they can put together. GC has done this rodeo before, so forgive him if he works on a schedule that doesn't comport with yours or the FDA's . You remember them? They're the other 800 pound Gorilla involved in this filing.
Ed, Any delay in filing is not as a result of GTHP dawdling. It takes two to tango, and there are repeated clarifications happening all the time between GTHP and the FDA. GTHP wants a response ASAP but they also want clarity in their response and the FDA will work at its own pace. I expect a filing within the next 2 weeks at which time, the clock in you head can tick off 180 days to either a nice Christmas present, or a good start to a new year.
Let GTHP continue to receive validations in the mean time. Eventually, everything that we discuss will be academic because Luviva has paid the piper in getting to where they're near the finish line.
It's not me who doesn't see upside, it's management. Not being able to tell us a drop dead date that they can envision delivering isn't the greatest "ATTA BOY" inspirer. This stock still may have some trades left in it, but I see the Asians just plodding along making stuff, where stuff changes so quickly, it makes your head spin. All I know is that any product that they do deliver will be looked at with a nanometer toothed comb. That costs time and money.
Now I see a bedraggled company that's trying to find its direction. Most speculation doesn't work out and why should UNXL be any different? If anything, at least last year there was a time when they had everyone believing that they'd do it on their own. I still get a kick out of that one.
What if those old employees contacted Barton? This is now about freedom. Maybe he's a nice guy and they want to work for him and last I checked, indentured servitude was outlawed along with slavery. Maybe Convatec stinks to work for.
If this isn't a patent infringement, load em up....................
Ed, our problem has always been that some of your complaints were just for complaints sake. For good or bad, GTHP does not have a large following at this point because they have disappointed in the past (emphasis on past). A lot of retail shareholders or even those considering being one, do not have fountains of relevant, timely information about GTHP. I hate to admit that even screeds on a Yahoo MB like yours can impact someones buying decisions to not even bother looking at GTHP since there are a lot of other companies out there.
My thoughts have always been to accentuate the fact that GTHP is a classic turnaround situation, with a CEO that seems completely overqualified for the humble task of running a micro cap diagnostic company. If you start with a premise like that as opposed to discussing things that are not of Cartwright's making or doing, you'd have a lot more supporters on this MB.
They've done a lot in the past 6 months. Cartwright straightened out Turkey to the point where they are billing 3 million to them in machines and disposables over the next 18 months. Nigeria, North Africa, Mexico and who knows where else.
Considering that Luviva could have qualified as the most innovative diagnostic product of 2013 since it was for all practical purposes in use last year, let me even sight the coincidence of Cartwright's selection as CEO as maybe helping get Luviva in contention. Who Knows?
Do you think that study out of the U.K. attesting to the 100% efficacy in detecting false positives grew on a tree? That studies genesis happened over a chance meeting in Canada that Cartwright had with a distributor and an influential doctor who cares about women and whose opinion obviously carried a lot of weight since the study was commissioned, completed and the data released.
As far as response to the FDA, do not rush it. That's what got the company in the predicament that I again have to remind you, Cartwright didn't cause.
So let me get this straight? If I post incessantly about UNXL, I'm a paid hack, and when I post infrequently, only prompted by events like that CC, I'm suspect? I am assuming that whatever formal education you do possess, you never once considered taking a logic course ?
No one wanted to believe in UNXL more than me. I go back to the run up to $40 where on the way back down I sold every share. I have bought and sold since and most of those experiences have been busts. If there were faith that they can produce and sell in volume with a clear picture about margins and production, the stock would be doing much better.
The SA article makes some salient points. The CEO is no doubt doing his best, but there's no one who can answer any questions about the cost to produce, the margins they make or how much have they had to give away to get to this point? There's no clear guidance about when it will be made commercially available and "what if" some Asian company does a technology leapfrog in the meantime?
I expect the stock to take a beating because a lot of the questions raised by the author, haven't been answered. Remember this stock when you think with such a huge short interest, how can you not get a short squeeze? Shorts risk more and I'll take their % of being right over longs any day.
What's the opposite of a short squeeze? Is it a long shunning? Well that's what I expect, a long shunning.
For his own personal reasons. It is his property isn't it? He does have t he right to sell it right? I'm not crazy about the mixed signals with Cartwright's buy, but I'm sure Hart has his reasons and I'd pay more mind to Cartwright's purchases than Hart's selling.
ED, I just wanted to warn you that you might be responding to your own posts just a tad too much lately. It's like this Message Board is your secret Genie in the bottle and if you rub enough people the wrong way, your wish will come true.
Is another reason why I have decided to rehate soccer. It's like getting a participation ribbon.
This is a steal. I just don't see Johnson abiding non performers. If any of these salespeople can't get excited about walking into a customers door with this product array, get rid of him/her. I made a mistake in not buying a boat load of HZNP when I saw that their bank account was building. Not this time.
I know that CELG could give a rat's rip about the stock, but I care that CELG owns 20% of it..
The only reason I wonder is because the stock wasn't acting like a stock that was on the threshold of greatness in the run up to yesterday's announcement. I also think that with the millions of shares that are short that need to cover, they'd just be running toward the exit pre market and buying price be damned. The stocks up because the news was good and frankly proof they can build, but this stock has baffled before and I don't think it's done quite yet. UNXL shorts have been among the most patient and stubborn investors I've ever seen.
I'll be looking to buy some, but I'm sick of thinking that it'll go parabolic like it did last year.
The market doesn't lie, This would have easily been past ten if they had shipped anything. I am looking to go bottom fishing again though after the next UNXL caused hysteria.
I know that they have lots of people doing lots of things, among them the refiling. Cartwright is good, but that refiling is no doubt being done by his colleague who does have a lot of experience before the FDA.. Cartwright will no doubt review before submission, but I prefer a lot of eyes and I'd rather see it done right, then just done at this point. Good stuff's going on and by the time this FDA thing happens, you're going to be seeing GTHP a lot higher based upon other things that you refused to give any credence to..
Ed, anytime I see a bid of .49 and a bid/ask at .50 .51, it does belie a tactic. Someone wants stock, and doesn't want to give any up. The minute you try to put even a small order in at .49, the MM moves it up.